| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.919118 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20230213104644 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 230113e20230120onc ob f000 0 eng d |
|---|
| 020 | |a9780660470702 |q(report) |
|---|
| 020 | |a9780660470719 |q(summary) |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP5-152/1-2023E-PDF |
|---|
| 086 | 1 |aHP5-152/2-2023E-PDF |
|---|
| 245 | 00|aGuidance on COVID-19 vaccine booster doses : |binitial considerations for 2023. |
|---|
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cJanuary 20, 2023. |
|---|
| 264 | 4|c©2023 |
|---|
| 300 | |a1 online resource (17 pages) + |esummary (8 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Directives sur les doses de rappel du vaccin contre la COVID-19 : premières considérations pour 2023. |
|---|
| 500 | |aOn cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). |
|---|
| 500 | |a"Pub.: 220696." |
|---|
| 500 | |a"Pub.: 220694." |
|---|
| 504 | |aIncludes bibliographical references (pages 15-17). |
|---|
| 650 | 0|aCOVID-19 vaccines|zCanada. |
|---|
| 650 | 0|aCOVID-19 (Disease)|xVaccination|zCanada. |
|---|
| 650 | 0|aCOVID-19 vaccines|xGovernment policy|zCanada. |
|---|
| 650 | 0|aCOVID-19 (Disease)|xVaccination|xGovernment policy|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
|---|
| 775 | 08|tDirectives sur les doses de rappel du vaccin contre la COVID-19 : |w(CaOODSP)9.919119 |
|---|
| 856 | 40|qPDF|s637 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-152-1-2023-eng.pdf|z(report) |
|---|
| 856 | 40|qPDF|s532 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-152-2-2023-eng.pdf|z(summary) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-covid-19-vaccine-booster-doses-initial-considerations-2023.html|z(report) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-covid-19-vaccine-booster-doses-initial-considerations-2023/summary-january-20-2023.html|z(summary) |
|---|
| 986 | |a220696 |
|---|
| 986 | |a220694 |
|---|